학술논문

Ocrelizumab exposure in relapsing-remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension
Document Type
Journal
Source
JOURNAL OF NEUROLOGY; OCT 31 2023, 16p.
Subject
Language
English
ISSN
14321459